2004•Unpublished venueRequires access

Drug Resistance Analysis on ESBLs-producing Gram-negative Bacilli to 12 Kinds of Antibacterial Drugs

Yalian Zhang

Open publisher page 0 citations

Abstract

OBJECTIVE To analyze the antibiotic resistance of ESBLs-producing Gram-negative bacilli to 12 kinds of antibacterial drugs. METHODS A total of 204 isolates from clinical specimens were screened for the presence of ESBLs by the VITEK ESBLs detection test and the double-disk synergy tests. In vitro antibacterial activity of 12 kinds of antibacterial drugs to ESBLs-producing Gram-negative bacilli were compared. RESULTS The detection rate of ESBLs was 23%. Of all ESBLs-producing bacilli,the productive rate of multi-resistant bacilli was 87.5%. Imipenem and meropenem had the most powerful antibacterial activity. Cefepime had weaker activity to ESBLs-producing bacilli. Cefoxitin, ofloxacin and aminoglycosides had powerful activity to ESBLs-producing Klebsiella pneumoniae. Piperacillin/tazobactam showed better activity to ESBLs-producing K. pneumoniae and Pseudomonas aeruginosa. CONCLUSIONS Carbapenem could be of the first choice to treat the infection caused by ESBLs-producing Gram-negative bacilli.

About this research paper

What this paper is about

OBJECTIVE To analyze the antibiotic resistance of ESBLs-producing Gram-negative bacilli to 12 kinds of antibacterial drugs. METHODS A total of 204 isolates from clinical specimens were screened for the presence of ESBLs by the VITEK ESBLs detection test and the double-disk synergy tests. In vitro antibacterial activity of 12 kinds of antibacterial drugs to ESBLs-producing Gram-negative bacilli were compared. RESULTS The detection rate of ESBLs was 23%. Of all ESBLs-producing bacilli,the productive rate of multi-resistant bacilli was 87.5%. Imipenem and meropenem had the most powerful antibacterial activity. Cefepime had weaker activity to ESBLs-producing bacilli. Cefoxitin, ofloxacin and aminoglycosides had powerful activity to ESBLs-producing Klebsiella pneumoniae. Piperacillin/tazobactam showed better activity to ESBLs-producing K. pneumoniae and Pseudomonas aeruginosa. CONCLUSIONS Carbapenem could be of the first choice to treat the infection caused by ESBLs-producing Gram-negative bacilli.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To analyze the antibiotic resistance of ESBLs-producing Gram-negative bacilli to 12 kinds of antibacterial drugs. METHODS A total of 204 isolates from clinical specimens were screened for the presence of ESBLs by the VITEK ESBLs detection test and the double-disk synergy tests. In vitro antibacterial activity of 12 kinds of antibacterial drugs to ESBLs-producing Gram-negative bacilli were compared. RESULTS The detection rate of ESBLs was 23%. Of all ESBLs-producing bacilli,the productive rate of multi-resistant bacilli was 87.5%. Imipenem and meropenem had the most powerful antibacterial activity. Cefepime had weaker activity to ESBLs-producing bacilli. Cefoxitin, ofloxacin and aminoglycosides had powerful activity to ESBLs-producing Klebsiella pneumoniae. Piperacillin/tazobactam showed better activity to ESBLs-producing K. pneumoniae and Pseudomonas aeruginosa. CONCLUSIONS Carbapenem could be of the first choice to treat the infection caused by ESBLs-producing Gram-negative bacilli.

Key concepts: Bacilli, Microbiology, Klebsiella pneumoniae, Piperacillin, Pseudomonas aeruginosa, Imipenem, Ofloxacin, Cefepime

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug Resistance Analysis on ESBLs-producing Gram-negative Bacilli to 12 Kinds of Antibacterial Drugs — Research Paper | ScholarLens